 |
 |
 |
Sandra A. Bresnick
New York Office Tel: 212-849-7000 Fax: 212-849-7100 sandrabresnick@quinnemanuel.com Practice Areas Intellectual Property Litigation Life Sciences Litigation Education
Boston University School Of Law (J.D., 1992)
Cornell University (A.B., with honors, Chemistry, 1986) |
Biography
Ms. Bresnick serves as Co-Chair of Quinn Emanuel's Global Life Sciences Litigation Practice. She focuses her practice on the trial and appeal of patent infringement actions and has particular experience litigating medical device and pharmaceutical cases. Recognized by Chambers USA as a leading lawyer in intellectual property, Ms. Bresnick teaches Pharmaceutical Patent Law at Rutgers University School of Law and is a member of the Board of Directors of The Progeria Research Foundation, a non-profit research organization dedicated to finding a treatment and cure for progeria. Representative Clients
Ethicon Endo-Surgery, Inc. Notable Representations
Notable Results:
Obtained 8-figure settlement for medical device client during trial.
Obtained summary judgment for innovator pharmaceutical client dismissing defenses of inequitable conduct, anticipation, and noninfringement in multi-defendant Hatch-Waxman litigation.
Obtained multi-million dollar settlement and permanent injunction for innovator pharmaceutical company in multi-defendant patent litigation immediately before trial.
Obtained preliminary injunction for innovator pharmaceutical company in multi-defendant patent litigation.
Defeated summary judgment of obviousness and summary judgment of lack of enablement in multi-defendant pharmaceutical patent litigations.
Notable Representations:
Lead trial counsel for patentee Ethicon Endo-Surgery in patent infringement litigations involving surgical breast biopsy systems.
Lead trial counsel for Ortho-McNeil Pharmaceutical, Inc., Ortho-McNeil Neurologics, Inc. and Janssen Ortho LLC in Hatch-Waxman litigation involving Axert®.
Lead trial counsel for MedPointe Healthcare, Inc. in multi-defendant patent infringement litigations involving MedPointe's Tussi-12D® products.
Trial counsel for ArthroCare Corp. in patent infringement litigation involving medical devices for spine surgery.
Trial and appellate counsel for Schering Corp. in multi-defendant ANDA litigations involving Schering's Claritin®, Claritin D®-12 and Claritin D®-24 brand antihistamine products.
Trial counsel for BioChem Pharma (now Shire BioChem) in patent infringement litigation involving Epivir® brand HIV therapy.
Trial counsel for defendants Solaray, Inc. and Neutraceuticals, Inc. in patent infringement suit involving defendants' IP-6® brand nutritional supplement.
Trial counsel for Hoechst-Marion Roussel in multi-defendant ANDA litigations involving Hoechst's Seldane® brand antihistamine.
Trial and appellate counsel for Tanabe Seiyaku Ltd. and Marion Merrell Dow, Inc. in patent infringement litigation in the U.S. Int'l Trade Comm'n involving Cardizem® brand diltiazem. |
|